Author Question: The extent to which people are devoted to their organizations and families is a. In-group ... (Read 59 times)

Tazate

  • Hero Member
  • *****
  • Posts: 532
The extent to which people are devoted to their organizations and families is
 
  a. In-group collectivisim
  b. Future orientation
  c. Institutional collectivism
  d. Humane orientation

Question 2

It seems that I keep making the same mistakes as I did when I was younger. I am applying which premise of the clinical paradigm?
 
  a. Mental life lies outside of conscious awareness
  b. Human development is an intra- and interpersonal process
  c. There is rationale behind every act
  d. How we regulate and express emotions is central to a person's identity



wtf444

  • Sr. Member
  • ****
  • Posts: 314
Answer to Question 1

A

Answer to Question 2

B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Glaucoma is a leading cause of blindness. As of yet, there is no cure. Everyone is at risk, and there may be no warning signs. It is six to eight times more common in African Americans than in whites. The best and most effective way to detect glaucoma is to receive a dilated eye examination.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

About 100 new prescription or over-the-counter drugs come into the U.S. market every year.

Did you know?

In 2012, nearly 24 milliion Americans, aged 12 and older, had abused an illicit drug, according to the National Institute on Drug Abuse (NIDA).

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library